Trials / Completed
CompletedNCT00581438
Study Evaluating Approach to Treatment of Haemophilia A and B in Spain
Actual Approach to Treatment of Haemophilia A and B in Spain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Analyze the clinical and therapeutic approach to treatment of haemophilia A and B in habitual clinical practice conditions in Spain.
Detailed description
Analyze the clinical and therapeutic approach to treatment of haemophilia A and B in habitual clinical practice conditions in Spain during the first 3 years since diagnosis. Assess haemophilia A or B patient profile, study different kinds of hanitual clinical treatment of haemophilia A and B patients, and estimate the kind of treatment and dosage units used per year in patients under habitual clinical practice conditions.
Conditions
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2007-12-27
- Last updated
- 2007-12-27
Source: ClinicalTrials.gov record NCT00581438. Inclusion in this directory is not an endorsement.